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Thus, the three major goals of future biomarker studies,
as discussed in our review, should be the following: (1) to
differentiate types of AKI at the time of diagnosis (acute
tubular necrosis vs. prerenal vs. other); (2) to predict or
diagnose AKI earlier than the ‘delayed’ clinical diagnosis
via creatinine; (3) to predict hard outcomes (need for
dialysis, length of stay, death) at the time of injury.3
In the absence of associations between biomarkers and
these hard end points, the availability of another
biomarker that ‘mimics’ creatinine will not be beneficial
in advancing the field of AKI. We would encourage
Ferrannini et al. to perform the analyses we have
mentioned in order to determine how cystatin C performs
for predicting these types of end points.
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To the Editor: The article by Davenport et al.1 suggests that
improved blood pressure control increases intradialytic
hypotension. It is unlikely that the reported higher incidence
of hypotension is caused by trying to achieve the Renal
Association targets alone.
In a study of 991 dialysis treatments in 111 patients over a
3-week period, we documented predialysis blood pressures of
136.9±23.4/67.8±14.0 mm Hg and postdialysis blood
pressures of 133.0±24.0/65.8±12.5 mm Hg. The Renal
Association targets were achieved by 56.8% of patients
predialysis, 44.1% postdialysis, and 37.8% achieved both
targets. Intradialytic hypotension occurred in 2.4% of all
treatments. No significant differences were demonstrated in
the blood pressure, interdialytic weight gains or prescribed
medication of those who experienced hypotension and those
who did not.
Two critical factors implemented in our unit may
contribute to these findings. We recognize that short dialysis
times make ultrafiltration more difficult to tolerate and
increase the potential for hypotension. Longer treatment
times are utilized whenever possible with the modal dialysis
time being 4.5 h. Our center utilizes postdilution hemodiafil-
tration as standard. There is increasing evidence that the use
of hemodiafiltration is associated with improvements in
blood pressure control, incidence of intradialytic hypotension
and a reduction in mortality.2–4
Predialysis hypertension does not obviate hypotension
episodes5 and not having targets for blood pressure control
will not necessarily reduce the frequency of hypotension
episodes. When improved control of blood pressure is
desired, modifications to the dialysis treatment itself should
be considered as part of the management strategy.
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High blood pressure is a major health issue in all regions of
the world,1 and myocardial infarction and stroke are the
commonest causes of death and disability worldwide.2
However, although there is a strong relationship between
blood pressure and the risk of cardio- and cerebrovascular
disease in the general population,1,2 this relationship is less
clear for hemodialysis patients, despite the increased
incidence of hypertension in this patient group. Assuming
a normal distribution, then the 95% confidence limits for
pre-dialysis blood pressure recordings were 183/95–91/
39 mm Hg, and 181/91–85/41 mm Hg post-dialysis record-
ings for the patients dialysing in Kilmarnock, and as such
only just over one-third of patients achieved the current
KDOQI blood pressure targets. Thus even in a single unit,
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